Immediate Versus Delayed Venous Thromboembolism Prophylaxis Following Spine Surgery: Increased Rate of Unplanned Reoperation for Postoperative Hematoma with Immediate Prophylaxis

Saturday, February 24, 2024

8:34 AM – 8:36 AM PST

Presenting Author(s)

Tariq Z. Issa, BA

Medical Student
Northwestern University Feinberg School of Medicine

Co-Author(s)

James S. Harrop, MD

Professor of Neurological Surgery
Jefferson Medical College
Philadelphia, Pennsylvania
AH

Alan S. Hilibrand, MD

Professor of Orthopaedic Surgery
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania
CK

Christopher Kepler, MD, MBA

Professor of Orthopaedic Surgery
Rothman Orthopaedic Institute
ML

Mark Lambrechts, MD

Assistant Professor
Washington University in St. Louis School of Medicine
YL

Yunsoo Lee, MD

Spine Fellow
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania
JS

Joseph Schaefer, MD

Resident
Thomas Jefferson University
GS

Gregory Schroeder, MD

Professor of Orthopaedic Surgery
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania
GT

Gregory R. Toci, MD

Resident
Rothman Orthopaedic Institute
Alexander Vaccaro, MD, PhD, MBA

Chairman, Department of Orthopaedic Surgery
Rothman Orthopaedic Institute at Thomas Jefferson University
Philadelphia, PA, US

Disclosure(s):

Tariq Z. Issa, BA: No financial relationships to disclose

James S. Harrop, M.D.: Depuy Spine: Advisor (Ongoing); NuVasive: Advisor (Ongoing); spiderwort: Advisor (Ongoing)

Alexander Vaccaro, M.D.: Accelus: Board Member/Officer/Trustee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Advanced Spinal Intellectual Properties: Stock Shareholder (excluding mutual funds) (Ongoing); AO Spine: Independent Contractor (Ongoing); ATEC: Royalty Recipient (Ongoing); Atlas Spine: Royalty Recipient (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Avaz Surgical: Stock Shareholder (excluding mutual funds) (Ongoing); AVKN Patient Driven Care: Stock Shareholder (excluding mutual funds) (Ongoing); Cytonics: Stock Shareholder (excluding mutual funds) (Ongoing); Deep Health: Stock Shareholder (excluding mutual funds) (Ongoing); Dimension Orthotics, LLC: Ownership or Partnership (Ongoing); Electrocore: Stock Shareholder (excluding mutual funds) (Ongoing); Elsevier: Royalty Recipient (Ongoing); Flagship Surgical: Stock Shareholder (excluding mutual funds) (Ongoing); FlowPharma: Stock Shareholder (excluding mutual funds) (Ongoing); Globus: Consultant (Ongoing), Royalty Recipient (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Harvard MedTech: Stock Shareholder (excluding mutual funds) (Ongoing); Innovative Surgical Design: Stock Shareholder (excluding mutual funds) (Ongoing); Jaypee: Royalty Recipient (Ongoing); Jushi (Haywood): Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Royalty Recipient (Ongoing); National Spine Health Foundation: Board Member/Officer/Trustee (Ongoing); NuVasive: Stock Shareholder (excluding mutual funds) (Ongoing); Orthobullets: Stock Shareholder (excluding mutual funds) (Ongoing); Parvizi Surgical Innovation: Stock Shareholder (excluding mutual funds) (Ongoing); Progressive Spinal Technologies: Stock Shareholder (excluding mutual funds) (Ongoing); Rothman Institute and Related Properties: Stock Shareholder (excluding mutual funds) (Ongoing); Sentryx Spine: Board Member/Officer/Trustee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Spinal Elements: Consultant (Ongoing), Royalty Recipient (Ongoing); SpineWave: Royalty Recipient (Ongoing); Stout Medical: Royalty Recipient (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Stryker Spine: Royalty Recipient (Ongoing); Surgalign: Stock Shareholder (excluding mutual funds) (Ongoing); Taylor Francis publishers: Royalty Recipient (Ongoing); Thieme: Royalty Recipient (Ongoing); ViewFi Health: Stock Shareholder (excluding mutual funds) (Ongoing); Wolters Kluwer: Royalty Recipient (Ongoing)